CRL Earnings Charles River Laboratories
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-27 | -0.03 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-28 | -0.30 | 2026-05-07 | 10-Q |
| Q4 2025 (derived) | 2025-12-27 | -5.57 | 2026-02-18 | 10-K |
| FY 2025 | 2025-12-27 | -2.91 | 2026-02-18 | 10-K |
| Q3 2025 | 2025-09-27 | 1.10 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-28 | 1.06 | 2025-08-06 | 10-Q |
| Q1 2025 | 2025-03-29 | 0.50 | 2025-05-07 | 10-Q |
| Q4 2024 (derived) | 2024-12-28 | -4.17 | 2025-02-19 | 10-K |
| FY 2024 | 2024-12-28 | 0.20 | 2025-02-19 | 10-K |
| Q3 2024 | 2024-09-28 | 1.33 | 2024-11-06 | 10-Q |
| Q2 2024 | 2024-06-29 | 1.74 | 2024-08-07 | 10-Q |
| Q1 2024 | 2024-03-30 | 1.30 | 2024-05-09 | 10-Q |
| Q4 2023 (derived) | 2023-12-30 | 3.63 | 2024-02-14 | 10-K |
| FY 2023 | 2023-12-30 | 9.22 | 2024-02-14 | 10-K |
| Q3 2023 | 2023-09-30 | 1.69 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-07-01 | 1.89 | 2023-08-09 | 10-Q |
| Q1 2023 | 2023-04-01 | 2.01 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 3.66 | 2023-02-22 | 10-K |
| FY 2022 | 2022-12-31 | 9.48 | 2023-02-22 | 10-K |
| Q3 2022 | 2022-09-24 | 1.88 | 2022-11-02 | 10-Q |
| Q2 2022 | 2022-06-25 | 2.13 | 2022-08-03 | 10-Q |
| Q1 2022 | 2022-03-26 | 1.81 | 2022-05-04 | 10-Q |
| Q4 2021 (derived) | 2021-12-25 | 2.67 | 2022-02-16 | 10-K |
| FY 2021 | 2021-12-25 | 7.60 | 2022-02-16 | 10-K |
| Q3 2021 | 2021-09-25 | 2.01 | 2021-11-03 | 10-Q |
| Q2 2021 | 2021-06-26 | 1.72 | 2021-08-04 | 10-Q |
| Q1 2021 | 2021-03-27 | 1.20 | 2021-05-04 | 10-Q |
| Q4 2020 | 2020-12-26 | 2.81 | 2021-02-17 | 10-K |
| FY 2020 | 2020-12-26 | 7.20 | 2021-02-17 | 10-K |
| Q3 2020 | 2020-09-26 | 2.03 | 2020-10-29 | 10-Q |
| Q2 2020 | 2020-06-27 | 1.34 | 2020-08-05 | 10-Q |
| Q1 2020 | 2020-03-28 | 1.02 | 2020-05-07 | 10-Q |
| Q4 2019 | 2019-12-28 | 1.61 | 2020-02-11 | 10-K |
| FY 2019 | 2019-12-28 | 5.07 | 2020-02-11 | 10-K |
| Q3 2019 | 2019-09-28 | 1.46 | 2019-11-06 | 10-Q |
| Q2 2019 | 2019-06-29 | 0.88 | 2019-07-31 | 10-Q |
| Q1 2019 | 2019-03-30 | 1.11 | 2019-05-07 | 10-Q |
| Q4 2018 | 2018-12-29 | 1.21 | 2019-02-13 | 10-K |
| FY 2018 | 2018-12-29 | 4.62 | 2019-02-13 | 10-K |
| Q3 2018 | 2018-09-29 | 1.22 | 2018-11-07 | 10-Q |
| Q2 2018 | 2018-06-30 | 1.10 | 2018-08-08 | 10-Q |
| Q1 2018 | 2018-03-31 | 1.08 | 2018-05-10 | 10-Q |
| Q4 2017 | 2017-12-30 | -0.63 | 2018-02-13 | 10-K |
| FY 2017 | 2017-12-30 | 2.54 | 2018-02-13 | 10-K |
| Q3 2017 | 2017-09-30 | 1.08 | 2017-11-09 | 10-Q |
| Q2 2017 | 2017-07-01 | 1.12 | 2017-08-09 | 10-Q |
| Q1 2017 | 2017-04-01 | 0.97 | 2017-05-10 | 10-Q |
| Q4 2016 | 2016-12-31 | 0.93 | 2017-02-14 | 10-K |
| FY 2016 | 2016-12-31 | 3.23 | 2017-02-14 | 10-K |
| Q3 2016 | 2016-09-24 | 0.79 | 2016-11-02 | 10-Q |
| Q2 2016 | 2016-06-25 | 0.73 | 2016-08-03 | 10-Q |
| Q1 2016 | 2016-03-26 | 0.78 | 2016-05-04 | 10-Q |
| Q4 2015 | 2015-12-26 | 0.67 | 2016-02-12 | 10-K |
| FY 2015 | 2015-12-26 | 3.13 | 2016-02-12 | 10-K |
| Q3 2015 | 2015-09-26 | 0.79 | 2015-11-04 | 10-Q |
| Q2 2015 | 2015-06-27 | 1.02 | 2015-07-30 | 10-Q |
| Q1 2015 | 2015-03-28 | 0.66 | 2015-04-30 | 10-Q |
| Q4 2014 | 2014-12-27 | 0.57 | 2015-02-17 | 10-K |
| FY 2014 | 2014-12-27 | 2.66 | 2015-02-17 | 10-K |
| Q3 2014 | 2014-09-27 | 0.68 | 2014-10-30 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.